FBIO Fortress Biotech, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
13:20
Jan 13
Jan 13
FBIO FDA approval for Menkes disease
The author claims FBIO can surge after receiving FDA approval for the first and only approved treatment for Menkes disease. The stated mechanism is eligibility for up to $129 million in milestones from Sentynl plus clinical data showing nearly 80% reduction in mortality risk with early treatment and a median OS of 177.1 months versus 17.6 months in the EC arm. The catalyst is the FDA approval announced today.
MED
About FBIO Investor Commentary
Across the available history and selected sources, Buzzberg tracks FBIO (Fortress Biotech, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/Anonycullen.